IN191512B - - Google Patents
Info
- Publication number
- IN191512B IN191512B IN46DE2000A IN191512B IN 191512 B IN191512 B IN 191512B IN 46DE2000 A IN46DE2000 A IN 46DE2000A IN 191512 B IN191512 B IN 191512B
- Authority
- IN
- India
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN46DE2000 IN191512B (pl) | 2000-01-21 | 2000-01-21 | |
AU44515/01A AU4451501A (en) | 2000-01-21 | 2001-01-19 | Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitor drugs for use transdermally and a process for the manufacture thereof |
PCT/IN2001/000007 WO2001052897A2 (en) | 2000-01-21 | 2001-01-19 | Therapeutic anti-inflammatory and analgesic composition containing selective cox-2 inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN46DE2000 IN191512B (pl) | 2000-01-21 | 2000-01-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN191512B true IN191512B (pl) | 2003-12-06 |
Family
ID=11097023
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN46DE2000 IN191512B (pl) | 2000-01-21 | 2000-01-21 |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU4451501A (pl) |
IN (1) | IN191512B (pl) |
WO (1) | WO2001052897A2 (pl) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020035107A1 (en) | 2000-06-20 | 2002-03-21 | Stefan Henke | Highly concentrated stable meloxicam solutions |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
IN191090B (pl) * | 2000-08-29 | 2003-09-20 | Ranbanx Lab Ltd | |
CZ20033241A3 (cs) * | 2001-05-31 | 2004-08-18 | Pharmaciaácorporation | Kůži prostupující přípravek obsahující selektivně inhibující cyklooxygenázu@@ a jednosytný alkohol |
DE10161077A1 (de) | 2001-12-12 | 2003-06-18 | Boehringer Ingelheim Vetmed | Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion |
BRPI0312007B1 (pt) * | 2002-06-25 | 2015-04-14 | Acrux Dds Pty Ltd | Composição farmacêutica para administração transcutânea de testosterona ou fentanil e uso da dita composição |
TW200418487A (en) * | 2002-09-17 | 2004-10-01 | Nippon Boehringer Ingelheim Co | Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer. |
US8992980B2 (en) | 2002-10-25 | 2015-03-31 | Boehringer Ingelheim Vetmedica Gmbh | Water-soluble meloxicam granules |
US20040127531A1 (en) * | 2002-11-21 | 2004-07-01 | Lu Guang Wei | Adhesive coated sheet for dermal delivery of a selective cyclooxygenase-2 inhibitor |
US20040126415A1 (en) * | 2002-11-21 | 2004-07-01 | Lu Guang Wei | Dermal delivery of a water-soluble selective cyclooxygenase-2 inhibitor |
US20050020658A1 (en) * | 2002-11-21 | 2005-01-27 | Katsuyuki Inoo | Selective cyclooxygenase-2 inhibitor patch |
WO2005044227A1 (en) * | 2003-11-05 | 2005-05-19 | Glenmark Pharmaceuticals Limited | Topical pharmaceutical compositions |
EP1568369A1 (en) | 2004-02-23 | 2005-08-31 | Boehringer Ingelheim Vetmedica Gmbh | Use of meloxicam for the treatment of respiratory diseases in pigs |
RO122835B9 (ro) * | 2006-12-19 | 2010-06-30 | Ion Fulga | Utilizarea dietilaminei ca analgezic în preparate farmaceutice |
JP5559339B2 (ja) | 2009-10-12 | 2014-07-23 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | メロキシカムを含む組成物のための容器 |
BR112012022073A2 (pt) | 2010-03-03 | 2017-10-31 | Boehringer Ingelheim Vetmedica Gmbh | uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos. |
US9795568B2 (en) | 2010-05-05 | 2017-10-24 | Boehringer Ingelheim Vetmedica Gmbh | Low concentration meloxicam tablets |
EA023000B1 (ru) * | 2012-10-25 | 2016-04-29 | Закрытое Акционерное Общество "Фармфирма "Сотекс" | Наружное средство для лечения болезней суставов и мягких тканей |
WO2016015094A1 (en) * | 2014-07-31 | 2016-02-04 | Acrux Dds Pty Ltd | Topical composition |
JP2018516279A (ja) * | 2015-05-29 | 2018-06-21 | コーダドース・インコーポレーテッド | 経口投与用のセレコキシブの液状配合物 |
CA3024205A1 (en) * | 2016-05-16 | 2017-11-23 | Delivra Inc. | Transdermal formulations for delivery of celecoxib and its use in the treatment of celecoxib-responsive diseases and conditions |
CN115916183A (zh) * | 2020-01-10 | 2023-04-04 | 布里奥里生物技术公司 | 含有罗非昔布的局部用组合物及其制备和使用方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GR81250B (en) * | 1983-12-22 | 1985-11-19 | American Home Prod | Menthol enhancement of transdermal drug delivery |
GB9019413D0 (en) * | 1990-09-05 | 1990-10-17 | Beecham Group Plc | Topical treatment and composition |
EP0782855B1 (en) * | 1994-10-05 | 2001-09-12 | Helsinn Healthcare S.A. | Nimesulide for external use |
ES2247604T3 (es) * | 1995-06-12 | 2006-03-01 | G.D. SEARLE & CO. | Composiciones que comprenden un inhibidor de ciclooxigenasa-2 y un inhibidor de 5-lipoxigenasa. |
HUP9601443A3 (en) * | 1996-05-29 | 1999-03-29 | Panacea Biotec Ltd | Injectable analgetic pharmaceutical compositions for intramuscular use containing nimesulid, and process for producing them |
GB9804886D0 (en) * | 1998-03-06 | 1998-04-29 | Merck Sharp & Dohme | Therapeutic combination |
PL345216A1 (en) * | 1998-06-29 | 2001-12-03 | Pharmaceuticals Applic Asociat | Methods and transdermal compositions for pain relief |
-
2000
- 2000-01-21 IN IN46DE2000 patent/IN191512B/en unknown
-
2001
- 2001-01-19 AU AU44515/01A patent/AU4451501A/en not_active Abandoned
- 2001-01-19 WO PCT/IN2001/000007 patent/WO2001052897A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
AU4451501A (en) | 2001-07-31 |
WO2001052897A2 (en) | 2001-07-26 |
WO2001052897A3 (en) | 2002-03-14 |